Shockwave Medical Valuation
| SWAVDelisted Stock | USD 268.45 6.44 2.34% |
At this time, the company appears to be overvalued. Shockwave Medical has a current Real Value of $234.04 per share. The regular price of the company is $268.45. Our model measures the value of Shockwave Medical from inspecting the company fundamentals such as Return On Equity of 0.25, shares outstanding of 37.54 M, and Operating Margin of 0.19 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Shockwave Medical's price fluctuation is very steady at this time. Calculation of the real value of Shockwave Medical is based on 3 months time horizon. Increasing Shockwave Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Shockwave stock is determined by what a typical buyer is willing to pay for full or partial control of Shockwave Medical. Since Shockwave Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Shockwave Stock. However, Shockwave Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 268.45 | Real 234.04 | Hype 268.45 |
The intrinsic value of Shockwave Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Shockwave Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Shockwave Medical helps investors to forecast how Shockwave stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shockwave Medical more accurately as focusing exclusively on Shockwave Medical's fundamentals will not take into account other important factors: Shockwave Medical Total Value Analysis
Shockwave Medical is at this time forecasted to have valuation of 12.32 B with market capitalization of 12.57 B, debt of 770.61 M, and cash on hands of 224.91 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Shockwave Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.32 B | 12.57 B | 770.61 M | 224.91 M |
Shockwave Medical Investor Information
About 99.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.38. Shockwave Medical had not issued any dividends in recent years. Based on the analysis of Shockwave Medical's profitability, liquidity, and operating efficiency, Shockwave Medical is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Shockwave Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Shockwave Medical has an asset utilization ratio of 46.61 percent. This indicates that the Company is making $0.47 for each dollar of assets. An increasing asset utilization means that Shockwave Medical is more efficient with each dollar of assets it utilizes for everyday operations.Shockwave Medical Ownership Allocation
Shockwave Medical shows a total of 37.54 Million outstanding shares. The majority of Shockwave Medical outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Shockwave Medical to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Shockwave Medical. Please pay attention to any change in the institutional holdings of Shockwave Medical as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Shockwave Medical Profitability Analysis
The company reported the previous year's revenue of 730.23 M. Net Income was 147.28 M with profit before overhead, payroll, taxes, and interest of 424.74 M.About Shockwave Medical Valuation
Our relative valuation model uses a comparative analysis of Shockwave Medical. We calculate exposure to Shockwave Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Shockwave Medical's related companies.ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company was incorporated in 2009 and is headquartered in Santa Clara, California. Shockwave Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 657 people.
Shockwave Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Shockwave Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 38.2 M | |
| Quarterly Earnings Growth Y O Y | 0.398 | |
| Forward Price Earnings | 68.4932 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Shockwave Stock
If you are still planning to invest in Shockwave Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shockwave Medical's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |